St. Johns Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Buy
5,261
+46
+0.9% +$16.4K 0.78% 31
2025
Q4
$1.71M Sell
5,215
-133
-2% -$42.2K 0.71% 36
2025
Q3
$1.51M Sell
5,348
-37
-0.7% -$10.7K 0.64% 38
2025
Q2
$1.5M Sell
5,385
-118
-2% -$33.4K 0.69% 37
2025
Q1
$1.71M Sell
5,503
-213
-4% -$62.9K 0.85% 33
2024
Q4
$1.49M Buy
5,716
+228
+4% +$67.6K 0.69% 39
2024
Q3
$1.77M Sell
5,488
-369
-6% -$121K 0.83% 35
2024
Q2
$1.83M Sell
5,857
-220
-4% -$64.6K 0.87% 31
2024
Q1
$1.73M Buy
6,077
+439
+8% +$128K 0.83% 35
2023
Q4
$1.62M Sell
5,638
-462
-8% -$126K 0.83% 34
2023
Q3
$1.64M Sell
6,100
-142
-2% -$35.4K 0.94% 29
2023
Q2
$1.39M Sell
6,242
-71
-1% -$16.5K 0.75% 37
2023
Q1
$1.53M Buy
6,313
+8
+0.1% +$1.96K 0.89% 33
2022
Q4
$1.66M Sell
6,305
-59
-0.9% -$15.8K 0.99% 27
2022
Q3
$1.43M Buy
6,364
+86
+1% +$20.8K 0.94% 31
2022
Q2
$1.53M Sell
6,278
-86
-1% -$21.1K 0.97% 28
2022
Q1
$1.54M Buy
6,364
+284
+5% +$65.3K 0.82% 34
2021
Q4
$1.37M Sell
6,080
-47
-0.8% -$9.92K 0.7% 45
2021
Q3
$1.3M Sell
6,127
-217
-3% -$49.9K 0.72% 44
2021
Q2
$1.55M Sell
6,344
-78
-1% -$19.2K 0.84% 39
2021
Q1
$1.6M Buy
6,422
+46
+0.7% +$11K 0.92% 37
2020
Q4
$1.47M Sell
6,376
-144
-2% -$33.2K 0.9% 34
2020
Q3
$1.66M Buy
6,520
+10
+0.2% +$2.48K 1.12% 26
2020
Q2
$1.53M Sell
6,510
-208
-3% -$47.5K 1.13% 25
2020
Q1
$1.36M Sell
6,718
-21
-0.3% -$4.59K 1.22% 25
2019
Q4
$1.63M Sell
6,739
-107
-2% -$23.6K 1.13% 26
2019
Q3
$1.32M Sell
6,846
-87
-1% -$16.7K 0.99% 34
2019
Q2
$1.28M Sell
6,933
-44
-0.6% -$7.88K 0.95% 36
2019
Q1
$1.32M Sell
6,977
-118
-2% -$22.5K 1.02% 33
2018
Q4
$1.38M Sell
7,095
-195
-3% -$38K 1.23% 23
2018
Q3
$1.51M Sell
7,290
-501
-6% -$98.7K 1.13% 23
2018
Q2
$1.44M Sell
7,791
-67
-0.9% -$11.9K 1.06% 28
2018
Q1
$1.34M Sell
7,858
-1
-0% -$184 1.01% 29
2017
Q4
$1.37M Sell
7,859
-400
-5% -$70.8K 1.01% 27
2017
Q3
$1.54M Sell
8,259
-195
-2% -$34.6K 1.13% 24
2017
Q2
$1.46M Buy
8,454
+411
+5% +$66.8K 1.1% 25
2017
Q1
$1.32M Sell
8,043
-33
-0.4% -$5.48K 1.05% 27
2016
Q4
$1.18M Sell
8,076
-146
-2% -$22K 0.98% 29
2016
Q3
$1.37M Buy
8,222
+71
+0.9% +$12K 1.15% 23
2016
Q2
$1.24M Buy
8,151
+93
+1% +$14.5K 1.12% 25
2016
Q1
$1.21M Buy
8,058
+10
+0.1% +$1.49K 1.07% 24
2015
Q4
$1.31M Sell
8,048
-40
-0.5% -$6.29K 1.18% 22
2015
Q3
$1.12M Sell
8,088
-97
-1% -$15.3K 1.05% 22
2015
Q2
$1.26M Sell
8,185
-95
-1% -$15.2K 1.08% 18
2015
Q1
$1.32M Sell
8,280
-813
-9% -$128K 1.16% 16
2014
Q4
$1.45M Sell
9,093
-265
-3% -$41.3K 1.26% 18
2014
Q3
$1.31M Buy
9,358
+28
+0.3% +$3.66K 1.16% 22
2014
Q2
$1.1M Buy
9,330
+10
+0.1% +$1.16K 0.95% 29
2014
Q1
$1.15M Buy
+9,320
New +$1.13M 1.03% 26

Other funds holding AMGN

St. Johns Investment Management's AMGN Position: Q1 2026 in Review

St. Johns Investment Management increased its Amgen (AMGN) stake by 0.88% in Q1 2026, buying an estimated $16.4K and bringing the position to 5,261 shares worth $1.85M. The position accounts for 0.78% of the portfolio, ranked #31.

St. Johns Investment Management first reported a position in AMGN in Q1 2014 and has held it in 49 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • St. Johns Investment Management held 5,261 shares of Amgen worth $1.85M as of Q1 2026.
  • St. Johns Investment Management bought 46 Amgen shares in Q1 2026, an estimated $16.4K.
  • Amgen made up 0.78% of St. Johns Investment Management's portfolio in Q1 2026, its #31 holding.
  • St. Johns Investment Management first reported a position in Amgen in Q1 2014 and has held it in 49 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on St. Johns Investment Management's 13F filing for Q1 2026, filed 28 Apr 2026.